Spectral Med Stock Performance
| EDT Stock | CAD 1.35 0.02 1.46% |
Spectral Med has a performance score of 3 on a scale of 0 to 100. The entity has a beta of 0.0575, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Spectral Med's returns are expected to increase less than the market. However, during the bear market, the loss of holding Spectral Med is expected to be smaller as well. Spectral Med right now has a risk of 2.68%. Please validate Spectral Med downside variance, day median price, and the relationship between the treynor ratio and kurtosis , to decide if Spectral Med will be following its existing price patterns.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Spectral Med are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Spectral Med may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Ex Dividend Date 2011-12-19 |
1 | Proactive Strategies - Stock Traders Daily | 12/24/2025 |
2 | Spectral Medical Stock Passes Below 50 Day Moving Average - Whats Next - MarketBeat | 12/31/2025 |
3 | Technical Patterns and Signals - Stock Traders Daily | 02/06/2026 |
| Begin Period Cash Flow | 3 M | |
| Total Cashflows From Investing Activities | -27 K | |
| Free Cash Flow | -8.8 M |
Spectral |
Spectral Med Relative Risk vs. Return Landscape
If you would invest 128.00 in Spectral Med on November 24, 2025 and sell it today you would earn a total of 7.00 from holding Spectral Med or generate 5.47% return on investment over 90 days. Spectral Med is generating 0.1208% of daily returns assuming 2.6806% volatility of returns over the 90 days investment horizon. Simply put, 24% of all stocks have less volatile historical return distribution than Spectral Med, and 98% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Spectral Med Target Price Odds to finish over Current Price
The tendency of Spectral Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.35 | 90 days | 1.35 | about 35.71 |
Based on a normal probability distribution, the odds of Spectral Med to move above the current price in 90 days from now is about 35.71 (This Spectral Med probability density function shows the probability of Spectral Stock to fall within a particular range of prices over 90 days) .
Spectral Med Price Density |
| Price |
Predictive Modules for Spectral Med
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Spectral Med. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Spectral Med Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Spectral Med is not an exception. The market had few large corrections towards the Spectral Med's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Spectral Med, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Spectral Med within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.01 | |
β | Beta against Dow Jones | 0.06 | |
σ | Overall volatility | 0.05 | |
Ir | Information ratio | -0.03 |
Spectral Med Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Spectral Med for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Spectral Med can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Spectral Med may become a speculative penny stock | |
| Spectral Med has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 2.29 M. Net Loss for the year was (15.39 M) with profit before overhead, payroll, taxes, and interest of 1.69 M. | |
| Spectral Med has accumulated about 3.8 M in cash with (8.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 18.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Technical Patterns and Signals - Stock Traders Daily |
Spectral Med Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Spectral Stock often depends not only on the future outlook of the current and potential Spectral Med's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Spectral Med's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 281.1 M | |
| Cash And Short Term Investments | 3 M |
Spectral Med Fundamentals Growth
Spectral Stock prices reflect investors' perceptions of the future prospects and financial health of Spectral Med, and Spectral Med fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Spectral Stock performance.
| Return On Equity | -9.74 | ||||
| Return On Asset | -0.87 | ||||
| Operating Margin | (4.13) % | ||||
| Current Valuation | 390.94 M | ||||
| Shares Outstanding | 289.14 M | ||||
| Price To Earning | (16.07) X | ||||
| Price To Book | 49.87 X | ||||
| Price To Sales | 144.30 X | ||||
| Revenue | 2.29 M | ||||
| Gross Profit | 1.69 M | ||||
| EBITDA | (11.97 M) | ||||
| Net Income | (15.39 M) | ||||
| Cash And Equivalents | 3.8 M | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 14.93 M | ||||
| Debt To Equity | 16.30 % | ||||
| Current Ratio | 6.95 X | ||||
| Book Value Per Share | (0.24) X | ||||
| Cash Flow From Operations | (8.82 M) | ||||
| Earnings Per Share | (0.14) X | ||||
| Market Capitalization | 428.82 M | ||||
| Total Asset | 5.32 M | ||||
| Retained Earnings | (140.84 M) | ||||
| Working Capital | (22.99 M) | ||||
About Spectral Med Performance
By examining Spectral Med's fundamental ratios, stakeholders can obtain critical insights into Spectral Med's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Spectral Med is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 75.81 | 72.02 | |
| Return On Tangible Assets | (3.44) | (3.27) | |
| Return On Capital Employed | 0.62 | 0.65 | |
| Return On Assets | (3.33) | (3.16) | |
| Return On Equity | 0.50 | 0.53 |
Things to note about Spectral Med performance evaluation
Checking the ongoing alerts about Spectral Med for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Spectral Med help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Spectral Med may become a speculative penny stock | |
| Spectral Med has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 2.29 M. Net Loss for the year was (15.39 M) with profit before overhead, payroll, taxes, and interest of 1.69 M. | |
| Spectral Med has accumulated about 3.8 M in cash with (8.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. | |
| Roughly 18.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Technical Patterns and Signals - Stock Traders Daily |
- Analyzing Spectral Med's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Spectral Med's stock is overvalued or undervalued compared to its peers.
- Examining Spectral Med's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Spectral Med's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Spectral Med's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Spectral Med's stock. These opinions can provide insight into Spectral Med's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Spectral Stock
Spectral Med financial ratios help investors to determine whether Spectral Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spectral with respect to the benefits of owning Spectral Med security.